National Path Lab
Kidney & Urinary Diseases

Diabetic Kidney Disease

Diabetes is one of the important risk factors for chronic kidney disease. Kidney damage associated with diabetes may develop gradually and can initially occur without symptoms.

Laboratory testing helps detect early albumin leakage and monitor kidney function — urine ACR can detect increased urinary albumin excretion even when kidney filtration is still relatively preserved, making it a valuable early-detection tool.

At National Path Lab (NPL), comprehensive diabetic kidney disease screening and monitoring testing is available.

Tests available
5
Tests available

Tests Available at NPL

CREATININE, SERUM

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 250

URINE EXAMINATION COMPLETE

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 200

GLYCOSYLATED HEMOGLOBIN; HBA1C

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1000

GFR (GLOMERULAR FILTRATION RATE), ESTIMATED

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 600

MICROALBUMIN CREATININE RATIO; ACR

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1200

About Diabetic Kidney Disease

Causes & Risk Factors

Diabetic kidney disease develops as a direct consequence of prolonged elevated blood glucose affecting the kidneys:

•  Duration of diabetes — risk increases with longer duration of diabetes, particularly if glucose control has been suboptimal.

•  Poor glucose control over time contributes directly to the kidney damage seen in diabetic kidney disease.

•  Coexisting hypertension significantly accelerates kidney damage in people with diabetes.

•  Genetic factors influence individual susceptibility to developing kidney complications from diabetes.

•  Smoking and obesity are additional contributing risk factors.

Symptoms & When to Test

Diabetic kidney disease, like CKD generally, is often asymptomatic in its earlier stages, which is why routine screening in diabetic patients is emphasized regardless of symptoms.

•  Often asymptomatic in early stages

•  Swelling in the legs or around the eyes, as disease progresses

•  Fatigue, in more advanced disease

•  Foamy or frothy urine, which can be a sign of significant protein loss

When Should You Consider Testing?

Routine annual screening with urine ACR and kidney function testing is generally recommended for all patients with diabetes, regardless of symptoms, given the silent nature of early diabetic kidney disease.

Why Tests Are Combined

Urine ACR and eGFR together provide the core assessment for diabetic kidney disease — urine ACR detects early albumin leakage (often the first detectable sign), while eGFR tracks overall filtration capacity, and monitoring both provides a more complete picture than either alone.

HbA1c is included specifically because it connects glucose control history to kidney risk — since the degree of glucose control over time is a key modifiable factor influencing whether and how quickly diabetic kidney disease develops or progresses.

Urinalysis complements ACR by screening for other urinary abnormalities (blood, glucose) that could indicate additional or alternative causes of urinary findings beyond diabetic kidney disease alone.

Tests Available at NPL

Test Code

Test

Clinical Relevance

B0052

 

Urine ACR

An important test for detecting albuminuria and early diabetic kidney involvement.

B0026

Creatinine

Assesses kidney function.

B0035

eGFR

Estimates the kidney's filtration capacity.

H0020

 

HbA1c

Assesses long-term blood glucose control, a key modifiable risk factor for diabetic kidney disease progression.

C0014

 

Urinalysis

Evaluates protein, blood, glucose, and other urinary abnormalities.

Preparation requirements vary by specific test — please follow the instructions provided by your doctor or NPL for the tests ordered.

Home Sample Collection

NPL offers convenient home sample collection for Diabetic Kidney Disease blood tests, so you don't need to visit a lab in person.

→ Book your test online, via the NPL app, or by calling +977 1 5970147 and select a convenient time slot for home sample collection.

→ A certified and experienced NPL phlebotomist visits your home at the scheduled time, following strict hygiene and safety protocols.

→ Your sample is transported under controlled, monitored conditions to NPL's NABL ACCREDITED UNDER ISO 15189:2012laboratory for processing.

→ Your digital report is delivered securely to your phone or email, along with access to download and share it as needed.

When to See a Doctor

•  Known diabetes — annual kidney screening (urine ACR and eGFR) is recommended regardless of symptoms

•  Swelling in the legs or around the eyes

•  Foamy or frothy urine

•  Diabetes with poor glucose control history — discuss kidney monitoring frequency with your doctor

Medical Disclaimer

Laboratory tests support the detection and monitoring of diabetic kidney disease but should not be interpreted in isolation. Reference ranges and clinical significance may vary according to the laboratory, patient characteristics, and clinical context. Final interpretation should be made by a qualified healthcare professional.

Frequently Asked Questions

Urine ACR can detect increased urinary albumin excretion even when kidney filtration is still relatively preserved. For people with diabetes, urine ACR combined with eGFR provides important information about kidney health and risk assessment.
Annual screening with urine ACR and eGFR is generally recommended for patients with diabetes, though your doctor may adjust this frequency based on your specific risk factors and prior results.
Urine ACR, creatinine, and eGFR usually do not require fasting. HbA1c also does not require fasting.
Good glucose control, blood pressure management, and regular screening for early detection are the key strategies for preventing or slowing diabetic kidney disease progression.
Early-stage albuminuria may sometimes improve with better glucose and blood pressure control, but more advanced kidney damage is generally not reversible, which underscores the value of early detection and management.